Starpharma Holdings Limited

SPHRF · OTC
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income$0-$8,165-$15,638-$16,154
Dep. & Amort.$0$0$1,193$1,079
Deferred Tax$0$0-$5,736-$4,590
Stock-Based Comp.$0$0$2,060$2,247
Change in WC$2,442$2,230-$1,042-$140
Other Non-Cash-$9,201-$1,042$5,630$4,396
Operating Cash Flow-$6,759-$6,977-$13,533-$13,162
Investing Activities
PP&E Inv.-$42-$89-$621-$837
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$11$1
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$42-$89-$610-$836
Financing Activities
Debt Repay.-$332-$4,002$83$4,000
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$796-$745-$778-$772
Financing Cash Flow-$1,128-$4,747-$695$3,228
Forex Effect-$24-$7$100$188
Net Chg. in Cash-$7,953-$11,820-$14,738-$10,582
Supplemental Information
Beg. Cash$23,360$35,180$49,918$60,500
End Cash$15,407$23,360$35,180$49,918
Free Cash Flow-$6,801-$7,066-$14,154-$13,999
Starpharma Holdings Limited (SPHRF) Financial Statements & Key Stats | AlphaPilot